期刊文献+

侧向层析技术标记物研究进展 被引量:3

Research advance of lateral flow assay labels
原文传递
导出
摘要 侧向层析技术以其简单、快速、灵敏、经济等优势广泛应用于即时检验、现场检验以及家庭自检中。合适的标记物的选择对整个实验的灵敏度起着重要作用。传统的标记物有胶体金、纳米硒以及纳米碳等,尤以胶体金最为常用。近年来新型标记物的出现,如量子点、纳米酶等,使得侧向层析有了进一步的发展,实现了从定性检测逐步向定量检测的转变。本文旨在介绍目前已有的侧向层析标记物,为侧向层析工作者筛选合适的标记物提供一定的研究依据。 Lateral flow assay is widely used in the point-of-care testing on-site and in-home testing with the advantage of being simple, rapid, sensitive and cost-effective. Proper labels are the key factors in lateral flow assay.Traditional labels include colloidal gold, selenium nanoparticle, and carbon nanoparticle, among which the colloidal gold is most commonly used. Lateral flow assay has been improved as a result of the discovery of new labels, such as quantum dots and nanozyme recently. Meanwhile, transformation of qualitative detection to quantitative detection is gradually realized. This article aims at introducing the most often used and the latest lateral flow assay labels, providing a basis theoretical investigation on screening proper labels for lateral flow assay researchers.
作者 靖静 王志增 JING Jing;WANG Zhizeng(Joint National Laboratory for Antibody Drug Engineering,Key Lab of Cellular and Molecular Immunology,School of Basic Medical Sciences,Henan University,Kaifeng,Henan 475004,P.R.Chin)
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2018年第4期661-664,共4页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(U1504823) 河南省科技发展计划项目(182102310154)
关键词 侧向层析 标记物 胶体金 纳米酶 lateral flow assay labels colloidal gold nanozyme
  • 相关文献

参考文献2

二级参考文献38

  • 1崔亚丽,惠文利,苏婧,王亚妮,陈超.Fe_3O_4/Au纳米复合粒子及其光学性质[J].中国科学(B辑),2005,35(2):89-93. 被引量:17
  • 2陈晓旭,郭哲.C-反应蛋白检测技术及临床应用[J].实用预防医学,2006,13(4):1098-1100. 被引量:10
  • 3Kilpatrick JM, Volanakis JE. Molecular genetics, structure, and function of C-reactive protein [ J ]. Immunol Res, 1991, 10 ( 1 ) : 45 - 53.
  • 4Pepys MB, l-lirschfield GM. C-reactive protein: a critical update [J]. J Clin Invest, 2003, 111(12) : 1805 -1812.
  • 5Rifai N, Ridker PM. High-sensitivity C-reaetive protein : a novel and premising marker of coronary heart disease[ J]. Clin Chem, 2001, 47(3) : 403 -411.
  • 6Buekley DI, Fu R, Freeman M, et al. C-reactive protein as a risk factor for coronary heart disease: a systematicreview and meta-analysesfor the U.S. Preventive Services Task Force[ J]. Ann Intern Med, 2009, 151(7) : 483 -495.
  • 7Singh SK, Suresh MV, Voleti B, et al. The connection between C-reactive protein and atherosclerosis [ J ]. Ann Med, 2008, 40(2) : 110 -120.
  • 8Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al, C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis[J]. Lancet, 2010, 375(9709): 132- 140.
  • 9Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events [ J ]. N Engl J Med, 2002, 347 ( 20 ) : 1557 - 1565.
  • 10Jiang S, Bao Y, Hou X, et al. Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population [ J]. Am J Cardiol, 2009, 103 (12) : 1727 - 1731.

共引文献18

同被引文献25

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部